The Patent Finder

Terms ending in 2031

The Institut Pasteur

Every in-force patent on The Institut Pasteur's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,164,107HMGB1 and ANTI-HMGB1 Antibodies for the Prognostic of Neurological Disorders
In force
 · Medium confidence
Institut PasteurIn forceMedium confidence
US 9,766,254HMGB1 and ANTI-HMGB1 Antibodies for the Prognostic of Neurological Disorders
In force
 · Medium confidence
Institut PasteurIn forceMedium confidence
US 9,329,132Method to Increase the Number of Detectable Photons During the Imaging of a Biological Marker
In force
 · High confidence
Institut PasteurIn forceHigh confidence
US 9,109,234Lentiviral Vector Based Immunological Compounds Against Malaria
In force
 · High confidence
Institut PasteurIn forceHigh confidence
US 8,883,173Synthetic Antigenic Peptides and Lipopeptides Derived from Mycobacterium Avium Subsp. Paratuberculosis
In force
 · High confidence
Institut PasteurIn forceHigh confidence
US 8,642,729Opiorphin Peptide Derivatives as Potent Inhibitors of Enkephalin-Degrading Ectopeptidases
In force
 · High confidence
Institut PasteurIn forceHigh confidence
US 8,858,931Polynucleotides Encoding MHC Class I-Restricted Htert Epitopes, Analogues Thereof or Polyepitopes
In force
 · High confidence
Institut Pasteur and Inserm (Institut National de la Sante et de la Recherche Medicale)In forceHigh confidence
US 9,546,380Mgmt-Based Method for Obtaining High Yeilds of Recombinant Protein Expression
In force
 · High confidence
Institut PasteurIn forceHigh confidence
US 9,109,219Mgmt-Based Method for Obtaining High Yeilds of Recombinant Protein Expression
In force
 · High confidence
Institut PasteurIn forceHigh confidence
9 of 9 patents shown. Soonest term end first, then patent number.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited